Great Point Partners’s Apyx Medical APYX Stock Holding History

Great Point Partners’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,829,441	Closed	-$6.18M	–	42
2017 Q3	$6.18M	Sell	1,829,441 -1,094,574	-37%	-$2.83M	1.53%	26
2017 Q2	$7.22M	Sell	2,924,015 -130,985	-4%	-$322K	1.39%	24
2017 Q1	$8.16M	Hold	3,055,000	–	–	1.79%	21
2016 Q4	$11M	Buy	3,055,000 +375,000	+14%	+$1.67M	2.42%	18
2016 Q3	$14M	Hold	2,680,000	–	–	3.64%	13
2016 Q2	$4.39M	Hold	2,680,000	–	–	1.29%	21
2016 Q1	$4.48M	Hold	2,680,000	–	–	1.71%	21
2015 Q4	$5.63M	Hold	2,680,000	–	–	2.47%	16
2015 Q3	$5.23M	Hold	2,680,000	–	–	2.25%	21
2015 Q2	$7.48M	Buy	2,680,000 +2,200,000	+458%	+$6.05M	2.96%	12
2015 Q1	$1.15M	Buy	+480,000	New	+$1.6M	0.52%	27

Other funds holding APYX

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Horizon Kinetics New York $2.96B AUM 5.37% 1-Year Est. Return

Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return